For the last decade, Ronald Ackermann, MD, MPH, has worked on implementing a method to halt diabetes that is both effective for patients and affordable for insurers. He and colleagues have focused on adapting an intervention called the Diabetes Prevention Program.
Monthly Archives: September, 2016
Northwestern’s biomaterials labs are developing the next generation of materials in medicine, called supramolecular biomaterials – molecules designed in a way to mimic cell structures and functions of biological signaling.
Northwestern Medicine scientists co-authored a study that identified a blood cell not normally found in the healthy brain that can invade brain tissue after status epilepticus, a type of seizure, and contributes to inflammation.
At Driskill day, students, faculty members and alumni celebrated accomplishments and research occurring in the Driskill Graduate Program in Life Sciences.
The senior project manager for the the Louis A. Simpson and Kimberly K. Querrey Biomedical Research Center shares the current progress on the construction of the university’s largest single construction project to date.
This year, the University launched a new Center for Synthetic Biology, making Northwestern one of the top three U.S. destinations for research and education in this area.
Victor Roy, an MD/PhD candidate, described the tension between pharmaceutical innovation and affordability in a recently published analysis.
Northwestern Medicine scientists have received a $7.5 million grant to study how genetic information from African American patients can predict their responses to medications.
National Institutes of Health Director Francis Collins and Illinois Sen. Dick Durbin spoke to an auditorium of nearly 300 physicians and researchers at Northwestern about the critical importance of sustaining momentum in medical research funding.